01 Escalating Chronic Conditions Are Driving Wound Care Demand The rise in chronic conditions such as diabetes, obesity, and vascular diseases is leading to a higher incidence of slow-healing wounds.Further, according to the International Diabetes Federation, diabetes-related neuropathy affects approximately 1 in 2 people living with diabetes, significantly increasing the risk of chronic wounds. These wounds often require long-term, advanced care solutions such as NPWT devices, hyperbaric oxygen therapy systems, and electrical stimulation devices.Thus, as the global chronic disease burden grows, so does the need for efficient wound care technologies to manage complications and improve patient outcomes.
02 Availability of Reimbursement Schemes for Wound Care Devices Reimbursement schemes are a key factor driving the adoption and growth of advanced wound care devices. By providing financial coverage for costly treatments, these schemes help reduce economic barriers and encourage healthcare providers to incorporate innovative technologies such as negative pressure wound therapy (NPWT).
01 Availability of Alternative Therapies Restrains Device Adoption The widespread use of advanced wound care products such as antimicrobial dressings, bioengineered skin substitutes, and topical growth factors presents a restraint for device-based therapies such as NPWT, oxygen therapy systems, and electric stimulation devices. These alternatives are often easier to apply, require less specialized equipment, and are more cost-effective, especially in outpatient or home care settings.Thus, clinicians may prefer these non-device options over complex wound care devices, slowing the adoption and market penetration of wound care devices.
01 Specialized Wound Care Clinics: Catalysts for Market Expansion The increasing number of specialized wound care clinics presents a significant opportunity for growth in the wound care devices market, as these clinics focus exclusively on treating complex and chronic wounds using advanced protocols.This growth leads to several key opportunities:Thus, the expansion of specialized wound care clinics offers opportunities for innovation, product diversification, and faster market growth.
July 2026 Mölnlycke Health Care launched three new wound care products in the U.S.—Granudacyn® Wound Wash Solution, Tortoise® Lite Turning and Positioning System, and Mepi® Press 2/Mepi® Press Lite Compression System—expanding its advanced wound care portfolio and strengthening its U.S. market presence.
May 2026 Smith+Nephew introduced ALLEVYN™ COMPLETE CARE Dressing and RENASYS™ EDGE topical negative pressure wound therapy (tNPWT) system at EWMA 2026, expanding its chronic wound care device portfolio with solutions designed to improve clinical outcomes and simplify wound management.
May 2026 Mölnlycke Health Care and Zhende Medical formed a joint venture in China to integrate their wound care portfolios and expand access to advanced wound care products through an extensive hospital, pharmacy, and e-commerce network.
May 2026 Kreate Medical received two U.S. FDA 510(k) clearances for its Antibacterial Absorbable Synthetic Matrix and Absorbable Synthetic Matrix product lines, marking the company's entry into the U.S. advanced wound care device market.